English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  51267187    線上人數 :  714
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"demetri g d"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 1-7 / 7 (共1頁)
1 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-03-15T05:39:20Z Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study Gounder M.; Sch?ffski P.; Jones R.L.; Agulnik M.; Cote G.M.; Villalobos V.M.; Attia S.; Chugh R.; WEI-WU CHEN; Jahan T.; Loggers E.T.; Gupta A.; Italiano A.; Demetri G.D.; Ratan R.; Davis L.E.; Mir O.; Dileo P.; Van Tine B.A.; Pressey J.G.; Lingaraj T.; Rajarethinam A.; Sierra L.; Agarwal S.; Stacchiotti S.
臺大學術典藏 2021-03-18T03:23:29Z Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study Gounder M.; Sch?ffski P.; Jones R.L.; Agulnik M.; Cote G.M.; Villalobos V.M.; Attia S.; Chugh R.; WEI-WU CHEN; Jahan T.; Loggers E.T.; Gupta A.; Italiano A.; Demetri G.D.; Ratan R.; Davis L.E.; Mir O.; Dileo P.; Van Tine B.A.; Pressey J.G.; Lingaraj T.; Rajarethinam A.; Sierra L.; Agarwal S.; Stacchiotti S.
臺大學術典藏 2020-03-07T06:52:13Z Dystrophin is a tumor suppressor in human cancers with myogenic programs Wang Y.; Marino-Enriquez A.; Bennett R.R.; Zhu M.; Shen Y.; Eilers G.; JEN-CHIEH LEE; Henze J.; Fletcher B.S.; Gu Z.; Fox E.A.; Antonescu C.R.; Fletcher C.D.M.; Guo X.; Raut C.P.; Demetri G.D.; Van De Rijn M.; Ordog T.; Kunkel L.M.; Fletcher J.A.
臺大學術典藏 2020-03-07T06:52:12Z KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation Serrano C.;Wang Y.;Mariño-Enríquez A;Jen-Chieh Lee;Ravegnini G.;Morgan J.A.;Bertagnolli M.M.;Beadling C.;Demetri G.D.;Corless C.L.;Heinrich M.C.;Fletcher J.A.; Serrano C.; Wang Y.; Mariño-Enríquez A.; JEN-CHIEH LEE; Ravegnini G.; Morgan J.A.; Bertagnolli M.M.; Beadling C.; Demetri G.D.; Corless C.L.; Heinrich M.C.; Fletcher J.A.
臺大學術典藏 2020-03-07T06:52:12Z KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation Serrano C.;Wang Y.;Mariño-Enríquez A;Jen-Chieh Lee;Ravegnini G.;Morgan J.A.;Bertagnolli M.M.;Beadling C.;Demetri G.D.;Corless C.L.;Heinrich M.C.;Fletcher J.A.; Serrano C.; Wang Y.; Mariño-Enríquez A.; JEN-CHIEH LEE; Ravegnini G.; Morgan J.A.; Bertagnolli M.M.; Beadling C.; Demetri G.D.; Corless C.L.; Heinrich M.C.; Fletcher J.A.
臺大學術典藏 2020-03-05T06:38:59Z Dystrophin is a tumor suppressor in human cancers with myogenic programs Wang Y.; Marino-Enriquez A.; Bennett R.R.; Zhu M.; Shen Y.; Eilers G.; JEN-CHIEH LEE; Henze J.; Fletcher B.S.; Gu Z.; Fox E.A.; Antonescu C.R.; Fletcher C.D.M.; Guo X.; Raut C.P.; Demetri G.D.; Van De Rijn M.; Ordog T.; Kunkel L.M.; Fletcher J.A.
臺大學術典藏 2015 KRAS and KIT gatekeeper mutations confer polyclonal primary imatinib resistance in GI stromal tumors: Relevance of concomitant phosphatidylinositol 3-kinase/AKT dysregulation Serrano C.; Wang Y.; Mari?o-Enr?quez A.; JEN-CHIEH LEE; Ravegnini G.; Morgan J.A.; Bertagnolli M.M.; Beadling C.; Demetri G.D.; Corless C.L.; Heinrich M.C.; Fletcher J.A.

顯示項目 1-7 / 7 (共1頁)
1 
每頁顯示[10|25|50]項目